Back to Stakeholders

Lykos Therapeutics

Also known as: MAPS Public Benefit Corporation

9 Trials

Public benefit company developing MDMA-assisted therapy programmes.

Quick Facts

Type: Public Benefit Corporation
Website: Visit

Sponsored Trials

9

Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD

Start Date: October 24, 2017
Compounds: MDMA

MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

Start Date: October 1, 2016
Compounds: MDMA

MDMA-assisted Psychotherapy for Anxiety Associated With a Life-threatening Illness

Start Date: January 4, 2015
Compounds: MDMA, Placebo

Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults

Start Date: January 2, 2014
Compounds: Placebo, MDMA

Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD

Start Date: January 9, 2013
Compounds: MDMA, Placebo

Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD

Start Date: October 1, 2012
Compounds: MDMA

Study Comparing Three Doses of MDMA Along With Psychotherapy in Veterans With Posttraumatic Stress Disorder

Start Date: January 10, 2010
Compounds: MDMA

Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder

Start Date: September 13, 2006
Compounds: MDMA

A Test of MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Start Date: March 12, 2004
Compounds: MDMA, Placebo